SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is actively discussed following its recent European Commission approval for the oncology drug ANKTIVA and a new distribution partnership spanning 33 countries. The community is buzzing with strong bullish sentiment, anticipating a significant short squeeze driven by these global expansion catalysts and substantial short interest.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

The FDA's unexpected reversal to review Moderna's seasonal flu vaccine application, after an initial refusal, is propelling the stock higher, leading to widespread community discussion of a significant short squeeze and optimism for its broader mRNA pipeline.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending after its earnings revealed robust revenue growth but a net loss, primarily due to higher loan loss provisions, which has led to a significant stock decline. While many in the community view it as a broken IPO with a questionable business model, others are aggressively buying the dip, confident in its strong user expansion and strategic market position within the struggling fintech sector.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space (FJET) is trending on the heels of its upcoming NYSE Opening Bell ceremony, sparking intense community speculation around a potential short squeeze due to its tight float, with many anticipating significant gains as the space sector heats up ahead of the highly anticipated Space X IPO.

Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts. The Construction and Forestry segment offers machines and service parts used in construction, earthmoving, road building, material handling and timber harvesting. The Financial Services segment finances sales and leases by John Deere dealers of new and used agriculture and turf equipment and construction and forestry equipment. The company was founded by John Deere in 1837 and is headquartered in Moline, IL.

Deere & Co.

Deere & Co

Deere & Co. is experiencing a significant rally following an earnings report that surpassed expectations and included raised guidance, with management signaling a bottoming of the agriculture cycle. However, community sentiment is sharply divided, as many question the sustainability of the surge given concerns about declining revenue, high debt, and valuation, while others celebrate the "homerun" and anticipate further upside.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending due to a competitor's recent regulatory setback and patent loss for its Cushing's syndrome treatment, which the community views as removing a significant competitive threat for Xeris's Recorlev and creating an irrational dip-buying opportunity. Investors are actively discussing the strong market position and growth potential of Recorlev and the upcoming earnings report, despite the stock's recent price action.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is a hot topic after its Q4 earnings, which, despite beating estimates, presented conservative forward guidance, sparking debate on its high valuation and a significant new $30 billion share buyback program amidst strong e-commerce and AI growth.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending sharply higher after securing $10.5 million in new U.S. Navy and defense contracts for its rugged Edge AI computing solutions. The community is highly bullish, citing undervaluation, a tight stock float, and anticipation of even larger defense and commercial robotics deals, believing the company is poised for significant growth in the Edge AI sector.

Booking Holdings, Inc. engages in the provision of online travel and related solutions. The firm offers services through the following brands: Booking.com, Priceline, Agoda, KAYAK, and OpenTable. It provides accommodation reservations including hotels, hostels, apartments, vacation rentals, and other properties. The company was founded by Jay Scott Walker on July 18, 1997, and is headquartered in Norwalk, CT.

Booking Holdings Inc

Booking Holdings is trending after its strong earnings beat, increased dividend, and announced 25-for-1 stock split surprisingly resulted in a significant sell-off. Community discussion is heavily focused on whether AI poses a genuine disruptive threat to the travel sector, particularly with Google's expanded AI travel tools, or if market concerns are overstated.

Medical Properties Trust, Inc. is a self-advised real estate investment trust. It engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie in 2003 and is headquartered in Birmingham, AL.

Medical Properties Trust Inc

Medical Properties Trust (MPT) is trending as its recent earnings report and strategic actions have energized a community bullish on its turnaround story, with aggressive call buying and high short interest fueling intense discussions about a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xeris Biopharma (NASDAQ:XERS) Trading Down 9.3% - Should You Sell?

Xeris Biopharma (NASDAQ:XERS) Trading Down 9.3% - Here's Why...

Xeris Biopharma Holdings, Inc. $XERS Shares Sold by CenterBook Partners LP

CenterBook Partners LP decreased its stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 56.2% during the third quarter, according to the company in its most recent...

Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight analysts that are covering the firm, MarketBeat.com...

Y Intercept Hong Kong Ltd Lowers Holdings in Xeris Biopharma Holdings, Inc. $XERS

Y Intercept Hong Kong Ltd decreased its position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 75.6% during the third quarter, according to the company in its most recent filing...

Insider Selling: Xeris Biopharma (NASDAQ:XERS) Insider Sells 16,667 Shares of Stock

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an...

Insider Selling: Xeris Biopharma (NASDAQ:XERS) Insider Sells 15,000 Shares of Stock

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Kevin Mcculloch sold 15,000 shares of the business's stock in a transaction on Thursday, January 8th. The shares were sold at an...

Xeris Biopharma (NASDAQ:XERS) Shares Gap Up - Here's Why

Xeris Biopharma (NASDAQ:XERS) Shares Gap Up - What's Next...

John Patrick Shannon, Jr. Sells 24,907 Shares of Xeris Biopharma (NASDAQ:XERS) Stock

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider John Patrick Shannon, Jr. sold 24,907 shares of Xeris Biopharma stock in a transaction that occurred on Monday, January 5th. The...

Xeris Biopharma (NASDAQ:XERS) Insider Sells $176,341.56 in Stock

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider John Patrick Shannon, Jr. sold 24,907 shares of the firm's stock in a transaction that occurred on Monday, January 5th. The...

Users view the current stock price as an unparalleled chance to buy undervalued shares, citing strong fundamentals and growth prospects for the business.

Traders believe the stock's recent decline is an irrational market reaction to a competitor's patent loss, misunderstanding its distinct market position.

The upcoming Q4 earnings call on March 2nd is eagerly awaited for strong 2026 guidance and signs of expanded profitability.

XERS
Xeris Biopharma Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XERS News

XERSXeris Biopharma Holdings Inc